A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

Clinical trial NCT02138799 · COMPLETED

Trial details

NCT number: NCT02138799
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-Drug Interaction (DDI)Healthy Subjects Pharmacokinetics of Enzalutamide

Start date: 2013-07-01
Primary completion: 2013-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.